The U.S. Food and Drug Administration (FDA) awarded a Firm Fixed Price Definitive Contract to the University of Sydney, doing business as the International Clinical Trials Symposium, to "IMPROVE SCIENTIFIC APPROACHES TO EVALUATE GENERIC DRUGS". The contract, valued at $1,234,519.00, has an ultimate completion date of September 29, 2025. The University of Sydney is a leading Australian educational institution that frequently collaborates with U.S. agencies and research organizations on pharmaceutical research and development projects. This contract builds on the university's prior work with the FDA on developing advanced testing methodologies for generic drugs, demonstrating its expertise in this area. The contract was awarded without any set-aside designations.
Generated 8/20/24, 9:23 AM